Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma × cemiplimab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Skin Neoplasms 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3 Squamous Cell Carcinoma of Head and Neck 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Sinonasal Squamous Cell Carcinoma 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mycosis Fungoides 1 Mouth Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Laryngeal Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 HPV-Related Squamous Cell Carcinoma 1

Interventions

Specimen Handling 6 Cyclophosphamide 5 Biopsy 5 Temozolomide 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 pazopanib 3 X-Rays 3 Vincristine 3 Trabectedin 3 Irinotecan 3 Ifosfamide 3 Doxorubicin 3 regorafenib 2 pembrolizumab 2 fludarabine 2 atezolizumab 2 Sirolimus 2 Radiation 2 Phantoms, Imaging 2 Metastasectomy 2 Interleukin-15 2 Gemcitabine 2 Etoposide 2 trastuzumab deruxtecan 1 tivozanib 1 temsirolimus 1 tazemetostat 1 talimogene laherparepvec 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡